1. Use of psychotropic drugs during pregnancy

   • F. Marchetti
   • M. Romero
   • Collaborative Group on Drug Use in Pregnancy (CGDUP)

   Originals Pages: 495 - 501

2. Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients

   • G. Martin
   • P. Forte
   • M. Velasco

   Originals Pages: 503 - 505

3. The consequences of H₂ receptor antagonist — piroxicam coadministration in patients with joint disorders

   • P. A. Milligan
   • P. E. McGill
   • B. Whiting

   Originals Pages: 507 - 512

4. Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia

   • E. Leitersdorf
   • S. Eisenberg
   • Y. Stein

   Originals Pages: 513 - 518

5. Transdermal nicotine in smoking cessation

   • A. Li Wan Po

   Originals Pages: 519 - 528

6. Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients

   • M. Dupon
   • G. Janvier
   • J. Saric

   Originals Pages: 529 - 534

7. Comparison of parameters of in vitro lymphocyte β₂-adrenoceptor function in normal and asthmatic subjects

   • D. M. Newnham
   • W. J. R. Coutie
   • B. J. Lipworth

   Originals Pages: 535 - 538

8. Central effects of combined bendrofluazide and atenolol administration

   • L. Gerrard
   • N. M. Wheeldon
   • D. G. McDevitt

   Originals Pages: 539 - 543

9. Pharmacokinetic model identification and parameter estimation as an ill-posed problem

   • H. Schwilden
   • J. Honerkamp
   • C. Elster

   Originals Pages: 545 - 550

10. The effect of probenecid on paracetamol metabolism and pharmacokinetics

    • F. Kamali

    Originals Pages: 551 - 553

11. Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients

    • A. E. Pontiroli
    • A. Calderara
    • S. R. Bareggi

    Originals Pages: 555 - 558

12. The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis

    • W. C. Shyu
    • K. A. Pittman
    • R. H. Barbhaiya

    Originals Pages: 559 - 562

13. Pharmacokinetics of chlorpromazine and key metabolites

    • P. K. -F. Yeung
    • J. W. Hubbard
    • K. K. Midha

    Originals Pages: 563 - 569

14. Lack of influence of short-term treatment with propranolol and terbutaline on metabolism and energy expenditure of the Na-K pump in human erythrocytes evaluated by microcalorimetry

    • B. Fagher
    • H. Liedholm
    • M. Monti

    Originals Pages: 571 - 576

15. Protein binding of digitoxin, valproate and phenytoin in sera from diabetics

    • J. Doucet
    • J. Fresel
    • N. Moore

    Short Communications Pages: 577 - 579

16. Pharmacodynamic modeling of cortisol suppression from fluocortolone

    • K. H. Lew
    • W. J. Jusko

    Short Communications Pages: 581 - 583

17. Flumazenil kinetics in the elderly

    • G. Roncari
    • U. Timm
    • W. Weber

    Short Communications Pages: 585 - 587

18. Hepatic elimination of ACE inhibitors

    • H. Schulz

    Letters To The Editors Pages: 589 - 589

19. Reply to the letter by H. Schulz

    • M. Nakashima

    Letters To The Editors Pages: 590 - 590

20. List of referees 1993

    Legacy Pages: 591 - 592

21. Announcements

    Announcement Pages: 593 - 593